The FTC just published a bot farm, a VPN email and 176 fake accounts. The line that lands on your clients is a ten percent discount.

Walk into almost any imaging center in the country and there's a version of the same laminated card near the checkout desk. Leave us a review. Usually there's a small thank-you attached — a discount on the next visit, a coffee card, a raffle entry around the holidays. Front-desk staff have been doing it for a decade. Nobody has ever filed it under advertising.

On July 14 the Federal Trade Commission issued a final order and complaint against a Nevada company called Vanilla Chip LLC, which sells supplements under the name TruHeight. The complaint runs thirty-six pages. Almost all of it is going to be somebody else's story.

Here's the inventory. The company bought approximately 176 Facebook and Instagram profiles that were, in the Commission's words, “software-automated bots.” The comments those accounts left were generated by ChatGPT — the outside contractor said so in writing, and volunteered his own quality figure: only fifteen comments in a hundred got flagged as fake. When the platforms began suspending accounts, a co-CEO emailed the contractor with instructions.

It keeps going. Several thousand five-star reviews on the company's own website, numerous ones written by its own employees. A YouTube testimonial in which someone reports growing two and a half inches in four months. A page on the site headed clinical study, pointing at a single company-sponsored trial of 32 participants that ran six months, lacked proper randomization, and never controlled for whether the kids slept or ate.

You read all that and you feel fine. You've never bought a bot. Neither has any client on your roster. Which is precisely why nearly everyone will close the PDF long before paragraph fifteen.

That's the whole thing. Ten percent off, and a sentence that asks nicely. The Commission charged it as Count V — a violation of Section 465.4 of the Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, which took effect October 21, 2024. The complaint goes out of its way to note the conduct continued after that date.

Both the bot farm and the discount are in this filing. Only one of them is something an ordinary practice does on a Tuesday afternoon.

The obvious objection is that this is a supplement company and your clients read scans. So go look at how the rule defines the businesses it covers. The Commission quoted its own definition in the complaint:

A radiology group sells services. So does the dermatology practice, the dental office, and the med spa down the road running a birthday-month promotion. I want to be precise about the reach here: the order binds one supplement seller in Nevada and nobody else. The rule it enforces is the general one, and it does not stop at the supplement aisle.

So here's my position, and it went to every client we have this morning. The ask is fine. The condition is not. Asking a patient to leave a review is ordinary and legal. Attaching a reward to a review is a different act from attaching a reward to a good review — and Section 465.4 lives entirely inside that difference, reaching incentives conditioned on sentiment “expressly or by implication.” In this case two words did the damage. Five-star.

Kept honest: the respondents neither admit nor deny the allegations, and every fact above is the Commission's as alleged in the complaint it issued July 14, 2026. The $4,000,000 is a liability figure entered and then suspended once $750,000 is paid, premised on the truthfulness of sworn financial statements — it is not a four-million-dollar check. TruHeight sells supplements, not scans, and none of this is legal advice; any practice's own exposure turns on its own facts and its own counsel. What isn't in question: the rule text, its effective date, and which paragraph the Commission chose to number as a count.

Sources (primary, verified today): FTC Final Complaint, In the Matter of Vanilla Chip LLC, also d/b/a TruHeight, Docket No. C-4837, issued July 14, 2026 — all quotations and paragraph numbers taken verbatim from the PDF (¶11 study of 32 participants; ¶15 the 10 percent discount and the “5-star review” language; ¶18 employee-written reviews; ¶21–23 approximately 176 purchased profiles, ChatGPT-generated comments, the VPN instruction; ¶32–35 the Reviews and Testimonials Rule, its October 21, 2024 effective date and its definition of “business”; Count V charged under § 465.4) · FTC Decision and Order, same docket, ISSUED July 14, 2026 (Provision VI, the permanent ban on incentives conditioned on sentiment; Provision VII, the $4,000,000 liability and the $750,000 payment schedule) · FTC case page (documents published July 15, 2026). Both PDFs were fetched and text-extracted during this run; the rule is codified at 16 C.F.R. Part 465.

The FTC published a final order last week against a supplement company, and the coverage is going to be about the bots. It should be.

The company bought roughly 176 Facebook and Instagram profiles that were software-automated. The comments were generated by ChatGPT. When the platforms started suspending accounts, a co-CEO emailed the contractor: "make sure to use VPN's and different IP addresses to avoid facebook detection." Several thousand five-star reviews on their own site, numerous ones written by their own employees.

Read that and you feel fine. You've never bought a bot. Neither have your clients.

Which is why almost nobody will get to paragraph 15.

Paragraph 15 is a 10 percent discount on the next order, offered to customers who would "take a moment to leave a 5-star review and upload at least one picture."

That's it. That's Count V — charged as a violation of Section 465.4 of the FTC's Reviews and Testimonials Rule, in effect since October 21, 2024. And the rule defines the businesses it covers as any "commercial entity that sells products or services." A radiology group sells services. So does your dental client, and the med spa running a birthday promo.

To be precise: the order binds one supplement seller in Nevada. The rule behind it binds everybody.

What I sent our clients this morning:

The ask is fine. The condition is not. Asking a patient for a review is ordinary and legal. Attaching a reward to a review is a different act from attaching a reward to a GOOD review — and 465.4 lives entirely in that gap. It reaches incentives conditioned on sentiment "expressly or by implication."

So go open the review-request email your practice actually sends. Not the one in the deck. Search it for "5-star," "positive," "happy," and any little row of stars. Check whether the discount sentence and the rating sentence share a breath. Then ask the front desk what they say out loud at checkout, and whether anyone on staff has ever written one.

Two words did the damage in this case. Five-star.

Source: FTC Final Complaint and Decision and Order, In the Matter of Vanilla Chip LLC d/b/a TruHeight, Docket C-4837, issued July 14, 2026. Paragraph numbers are in the PDF. The respondents neither admit nor deny.

FIRST SOURCE · one verified original-source finding, composed for one reader · this edition: healthcare practice marketing — written for imaging-center owners and the agencies that write their copy